Please do not adjust margins
Green Chemistry
Page 4 of 6
DOI: 10.1039/C7GC01575E
COMMUNICATION
Journal Name
4
5
6
Y. E. Jad, G. A. Acosta, S. N. Khattab, B. G. de la Torre, T.
Govender, H. G. Kruger, A. El-Faham and F. Albericio, Amino
Acids, 2016, 48, 419.
Table 4 Determination of extent of epimerization under optimized conditions
O
O
H
H
N
O
Y. E. Jad, G. A. Acosta, S. N. Khattab, B. G. de la Torre, T.
Govender, H. G. Kruger, A. El-Faham and F. Albericio, Org.
Biomol. Chem., 2015, 13, 2393.
N
H
Cbz
OH
Cbz
N
R
OEt
+
N
OEt
H
O
(2a)
S. Lawrenson, M. North, F. Peigneguy and A. Routledge, Green
Chem., 2017, 19, 952.
Entry
1
-R
Conditions
eea
7
8
9
A. El-Faham and F. Albericio, J. Pept. Sci., 2010, 16, 6.
J. C. Sheehan and J. J. Hlavka, J. Org. Chem., 1956, 21, 439.
G. I. Tesser and I. C. Balvert-Geers, Int. J. Pept. Res. Ther., 1975,
7, 295.
H·HCl
CBz
COMU, 2.6-lutidine, TPGS-750-M/H2O
> 99 %
> 99 %
1) Pd/C, H2, HCl, TPGS-750-M/H2O
2) COMU, 2.6-lutidine
2
a Determined by chiral HPLC analysis
10 K. Hojo, M. Maeda and K. Kawasaki, Tetrahedron Lett., 2004, 45,
9293.
While E Factors for pharmaceuticals are typically between 25
and 100, due to the stepwise nature of chemical peptide
synthesis, values are estimated to be 100 times larger.32 Here,
the reduced amounts of organic solvent used for extraction,
and the step-economy involved, led to E Factors of 15 and 10
based on organic solvent used both with, and without, water
in the calculations, respectively (Figure 2).
11 K. Hojo, M. Maeda and K. Kawasaki, Tetrahedron, 2004, 60,
1875.
12 H. Kunz, Angew. Chem. Int. Ed. Engl., 1978, 17, 67.
13 K. Hojo, H. Ichikawa, M. Onishi, Y. Fukumori and K. Kawasaki, J.
Pept. Sci., 2011, 17, 487.
14 K. Hojo, H. Kitai, M. Onishi, H. Ichikawa, Y. Fukumori and K.
Kawasaki, Chem. Cent. J., 2011, 5, 49.
15 K. Hojo, H. Ichikawa, Y. Fukumori and K. Kawasaki, Int. J. Pept.
Res. Ther., 2008, 14, 373.
Conclusion
16 K. Hojo, H. Ichikawa, M. Maeda, S. Kida, Y. Fukumori and K.
Kawasaki, J. Pept. Sci., 2007, 13, 493.
An efficient technology has been developed that dramatically
reduces the environmental impact of traditional solution-
based polypeptide synthesis that relies on
a tandem
17 B. Bacsa, K. Horvati, S. Bosze, F. Andreae and C. O. Kappe, J. Org.
Chem., 2008, 73, 7532.
deprotection/peptide coupling under mild aqueous micellar
conditions. This approach is broadly applicable to several types
of amino acids that contain differing polarities, as well as an
array of varying substitution patterns on their side chains,
including phenyl or alkyl moieties, protected amine or
carboxylic acid, and unprotected alcohol and phenolic groups.
The polypeptide length has been extended to ten amino acid
residues without significant loss of efficiency. Elimination of
two environmentally egregious organic solvents (DCM or DMF)
has been demonstrated, while the associated E Factors as a
measure of waste generated have dropped to 10 for this 2-
step sequence. Access to cyclic peptides by this methodology
is under active investigation.
18 A. S. Galanis, F. Albericio and M. Grotli, Org. Lett., 2009, 11,
4488.
19 K. Hojo, N. Shinozaki, K. Hidaka, Y. Tsuda, Y. Fukumori, H.
Ichikawa and J. D. Wade, Amino Acids, 2014, 46, 2347.
20 A. Mahindra, N. Patel, N. Bagra and R. Jain, RSC Adv., 2014, 4,
3065.
21 M. Ueki, N. Nishigaki, H. Aoki, T. Tsurusaki and T. Katoh, Chem.
Lett., 1993, 721.
22 C. Zorn, F. Gnad, S. Salmen, T. Herpin and O. Reiser, Tetrahedron
Lett., 2001, 42, 7049.
23 C. M. Gabriel, M. Keener, F. Gallou and B. Lipshutz H., Org. Lett.,
2015, 17, 3968.
24. While the Fmoc group might well be amenable to this
Acknowledgments
deprotection/coupling sequence, the methylenefluorene by-
product becomes organic waste, in addition to the base and
resulting salts that end up in the aqueous phase, also as waste.
Hence, the Cbz group appears to be the greenest option.
The financial support provided by Greentech as well as the
instrumentation support from NIH (1S10OD012077) are
gratefully acknowledged.
25 A. Bhattacharjya, P. Klumphu and B. Lipshutz H., Org. Lett.,
2015, 17, 1122.
Notes and references
26 Sigma Aldrich (01/17/17): Pd/C 10%: $26.5/g vs. PdCl2 $56.2/g.
27 For serine, performed with NMM to avoid the formation of an
acyl-pyridinium intermediate. For more details, see: Org.
Process Res. Dev., 2016, 20, 1104.
1
2
3
D. G. Brown and J. Boström, J. Med. Chem., 2016, 59, 4443.
S. D. Roughley and A. M. Jordan, J. Med. Chem., 2011, 54, 3451.
Peptide Therapeutics Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast 2012 - 2018, Transparency
Market Research, 2013.
28 C. M. Gabriel, N. R. Lee, F. Bigorne, P. Klumphu, M. Parmentier,
F. Gallou and B. Lipshutz H., Org. Lett., 2017, 19, 194.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins